← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Estrella Immunopharma ESLA $14M	9	+1	+13%	$8.18M
102	102 NewcelX Ltd NCEL $15.3M	7	+1	+17%	$7.11M
103	TCBP 103 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	6	+3	+100%	$380K
104	KRBP 104 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	5	-2	-29%	$6.13K
105	ATNX 105 DELISTED Athenex, Inc. Common Stock ATNX	4	-26	-87%	$8.93K
106	BLCM 106 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	4	-21	-84%	$173K
107	107 Genenta Science GNTA $32.5M	4	+2	+100%	$2.73M
108	PTE 108 DELISTED PolarityTE, Inc. Common Stock PTE	3	-20	-87%	$20
109	CYAD 109 DELISTED Celyad Oncology SA American Depositary Shares CYAD	2	-6	-75%	$9.27K
110	110 CytoMed Therapeutics GDTC $10.1M	1	+1	–	$165
111	SIOX 111 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	1	-3	-75%	$26K
112	ONCS 112 DELISTED OncoSec Medical Incorporated ONCS	0	-12	-100%	$0
113	RUBY 113 DELISTED Rubius Therapeutics, Inc RUBY	0	-7	-100%	$0
114	TCRR 114 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	0	-59	-100%	$0
115	AGTC 115 DELISTED Applied Genetic Technologies Corporation AGTC	–	–	–	–
116	AKUS 116 DELISTED Akouos Inc AKUS	–	–	–	–
117	117 Artiva Biotherapeutics ARTV $294M	–	–	–	–
118	118 DELISTED CARGO Therapeutics CRGX	–	–	–	–
119	119 enGene Therapeutics ENGN $110M	–	–	–	–
120	120 FibroBiologics FBLG $7.29M	–	–	–	–
121	121 Fractyl Health GUTS $54.3M	–	–	–	–
122	122 Kyverna Therapeutics KYTX $364M	–	–	–	–
123	LOGC 123 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–
124	124 Lexeo Therapeutics LXEO $227M	–	–	–	–
125	125 Metagenomi Therapeutics MGX $32.3M	–	–	–	–